Health·Google News - Business·8/26/2026, 3:23:53 PM·

F.D.A. Approves Drug Poised to Transform Care for Pancreatic Cancer - The New York Times

The FDA has approved a new pancreatic cancer drug from Revolution Medicines called Rasonque, marking a breakthrough in KRAS-targeted therapy. The medication is expected to potentially double survival time for patients with this deadly disease, representing a significant advancement in treatment options for pancreatic cancer, which has historically had limited therapeutic choices.

AI-generated summary. Social Pulse does not publish the full article. This brief is a neutral paraphrase by AI. Read the original at Google News - Business using the link below.

Read Original Article

Related briefs

Reuters - World (Google News)
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug - Reuters
Google News - Business
FDA approves landmark pancreatic cancer drug that’s shown to improve survival - AP News
Google News - Health
Florida Moves to Let Children Attend School Without 4 Previously Required Vaccines - Currently.com
Google News - Health
What We Know About Australia’s Bird Flu, Which Has Crossed Over to Mammals - The New York Times
Google News - Business
FDA approves new blood test for Alzheimer’s disease - The Hill
Google News - Health
These Babies Grew Up With Strict Sugar Limits. Decades Later, The Results Are Dramatic. - ScienceAlert

COMMENTS · 0

Join the conversation

Be the first to comment.